Phase I trial of metronomic oral vinorelbine in patients with advanced cancer

被引：0
|
作者：
Lakshmi Rajdev
Abdissa Negassa
Qun Dai
Gary Goldberg
Kathy Miller
Joseph A. Sparano
机构：
[1] Albert Einstein College of Medicine and Cancer Center,Department of Oncology
[2] Montefiore Medical Center,Department of Epidemiology and Population Health, Division of Biostatics
[3] Albert Einstein College of Medicine and Cancer Center,Department of Medical Oncology
[4] Staten Island University Hospital,Department of Obstetrics, Gynecology, and Women’s Health, Division of Gynecologic Oncology
[5] Albert Einstein College of Medicine and Cancer Center,Department of Medicine, Division of Hematology/Oncology
[6] Montefiore Medical Center,undefined
[7] Indiana University School of Medicine,undefined
来源：
Cancer Chemotherapy and Pharmacology | 2011年 / 68卷
关键词：
Metronomic; Oral; Vinorelbine; Advanced cancer;
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
页码：1119 / 1124
页数：5
相关论文
共 50 条
  • [21] Gemcitabine and vinorelbine in patients with advanced lung cancer: preclinical studies and report of a phase I trial
    Herbst, RS
    Lynch, C
    Vasconcelles, M
    Teicher, BA
    Strauss, G
    Elias, A
    Anderson, I
    Zacarola, P
    Dang, NH
    Leong, T
    Salgia, R
    Skarin, AT
    CANCER CHEMOTHERAPY AND PHARMACOLOGY, 2001, 48 (02) : 151 - 159
  • [22] Oral Metronomic Vinorelbine in Advanced Non-small Cell Lung Cancer Patients Unfit for Chemotherapy
    Banna, Giuseppe L.
    Camerini, Andrea
    Bronte, Giuseppe
    Anile, Giuseppe
    Addeo, Alfredo
    Rundo, Francesco
    Zanghi, Guido
    Lal, Rohit
    Libra, Massimo
    ANTICANCER RESEARCH, 2018, 38 (06) : 3689 - 3697
  • [23] Metronomic oral vinorelbine (VNB) for treatment of advanced breast cancer (BC) patients (pts): A retrospective analysis
    Foltran, L.
    Bertola, M.
    Sulfaro, S.
    Del Conte, A.
    Baresic, T.
    Favero, A.
    Bassini, A.
    Lorenzon, M.
    Tumolo, S.
    Saracchini, S.
    EUROPEAN JOURNAL OF CANCER, 2014, 50 : S182 - S182
  • [24] A Dose-finding Study of Metronomic Oral Vinorelbine in Combination With Oral Cyclophosphamide and Bevacizumab in Patients With Advanced Breast Cancer
    Sanna, Giuseppina
    Pestrin, Marta
    Moretti, Erica
    Biagioni, Chiara
    De Santo, Irene
    Gabellini, Stefano
    Galardi, Francesca
    McCartney, Amelia
    Biganzoli, Laura
    CLINICAL BREAST CANCER, 2021, 21 (04) : E332 - E339
  • [25] Treatment of advanced recurrent NSCLC with daily oral vinorelbine: A phase I trial.
    Tufman, Amanda
    Borgmeier, Astrid
    Guetz, Sylvia
    Von Pawel, Joachim
    Rittmeyer, Achim
    Huber, Rudolf M.
    JOURNAL OF CLINICAL ONCOLOGY, 2013, 31 (15)
  • [26] Phase I and pharmacokinetic study of weekly oral therapy with vinorelbine in patients with advanced breast cancer (ABC)
    Bonneterre, J
    Chevalier, B
    Focan, C
    Mauriac, L
    Piccart, M
    ANNALS OF ONCOLOGY, 2001, 12 (12) : 1683 - 1691
  • [27] Metronomic oral vinorelbine as first-line treatment in elderly patients with advanced non-small cell lung cancer: Preliminary results of a phase II trial (move trial)
    Camerini, A.
    Donati, S.
    Valsuani, C.
    Puccetti, C.
    Petrella, M. C.
    Tartarelli, G.
    Puccinelli, P.
    Amoroso, D.
    EUROPEAN JOURNAL OF CANCER, 2013, 49 : S825 - S825
  • [28] METRONOMIC ORAL VINORELBINE IN PATIENTS WITH METASTATIC BREAST CANCER (MBC): A PHASE II STUDY IN OUR INSTITUTION
    Nastasi, G.
    Cotroneo, G.
    Roda, G.
    Duluc, M.
    Castro, A.
    Maffioletti, L.
    Ravenda, P. S.
    ANNALS OF ONCOLOGY, 2009, 20
  • [29] A phase I trial of docetaxel and vinorelbine in patients with advanced non-small cell lung cancer
    Govindan, R
    Lim, WT
    Arquette, MA
    Goodner, SA
    Fears, CL
    Mortimer, JE
    Fracasso, PM
    ONCOLOGY REPORTS, 2006, 15 (01) : 123 - 127
  • [30] A phase II trial of low-dose metronomic oral vinorelbine as salvage treatment in advanced non-small cell lung cancer (NSCLC)
    Agelaki, S.
    Kontopodis, E. D.
    Kentepozidis, N.
    Giassas, S.
    Vamvakas, L.
    Androulakis, N.
    Kotsakis, K.
    Sfakiotaki, G.
    Mavroudis, D.
    Georgoulias, V
    JOURNAL OF THORACIC ONCOLOGY, 2009, 4 (09) : S448 - S448
12345